Literature DB >> 35496760

Multimodal imaging reveals retinoschisis masquerading as retinal detachment in patients with choroideremia.

Luciano C Greig1,2, Karen G Gutierrez1,2, Jin Kyun Oh3,4, Sarah R Levi3,4, Edward Korot2, Stephen H Tsang3,4, Vinit B Mahajan1,2,5.   

Abstract

Purpose: To report three cases of retinoschisis in patients with intermediate to advanced choroideremia. Observations: Three patients were referred for evaluation of retinal detachment in the context of an inherited retinal degenerative disease. In all three cases, patients carried variants in the CHM gene suspected to be pathogenic and exhibited the characteristic findings of choroideremia, including pigment clumping and chorioretinal atrophy with scleral exposure and prominent choroidal vessels. Interestingly, these patients were also found to have areas of typical retinoschisis and cystoid degeneration located in the outer plexiform layer of the mid periphery or macula. Retinoschisis was confirmed by spectral domain optical coherence tomography (SD-OCT). Conclusions/Importance: This paper draws attention to the occurrence of retinoschisis in patients with choroideremia. OCT can be used to confirm the presence of retinoschisis rather than retinal detachment, as the clinical exam findings that distinguish the two conditions are not helpful in the setting of advanced chorioretinal atrophy. Although it remains unclear whether patients with choroideremia as a group are at increased risk of retinoschisis, it is possible that abnormal vesicular traffic in the RPE and photoreceptors could contribute to abnormalities in cell adhesion and the extracellular matrix. As gene therapy by subretinal injection of adeno-associated virus becomes the standard of care to slow down or arrest retinal degeneration in choroideremia, it will be critical to carefully screen these patients for retinoschisis prior to surgical intervention and to incorporate any such findings into surgical planning.
© 2022 Published by Elsevier Inc.

Entities:  

Keywords:  CHM; Choroideremia; Optical coherence tomography; Retinal detachment; Retinoschisis

Year:  2022        PMID: 35496760      PMCID: PMC9052045          DOI: 10.1016/j.ajoc.2022.101543

Source DB:  PubMed          Journal:  Am J Ophthalmol Case Rep        ISSN: 2451-9936


  19 in total

1.  Typical and reticular degenerative retinoschisis.

Authors:  B R Straatsma; R Y Foss
Journal:  Am J Ophthalmol       Date:  1973-04       Impact factor: 5.258

2.  Clinical study of senile retinoschisis.

Authors:  N E Byer
Journal:  Arch Ophthalmol       Date:  1968-01

3.  Prevalence and long-term natural course of retinoschisis among elderly individuals: the Copenhagen City Eye Study.

Authors:  Helena Buch; Troels Vinding; Niels V Nielsen
Journal:  Ophthalmology       Date:  2007-01-02       Impact factor: 12.079

Review 4.  Choroideremia: new findings from ocular pathology and review of recent literature.

Authors:  Ian M MacDonald; Laurie Russell; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2009 May-Jun       Impact factor: 6.048

5.  Long-term natural history study of senile retinoschisis with implications for management.

Authors:  N E Byer
Journal:  Ophthalmology       Date:  1986-09       Impact factor: 12.079

6.  The Spectrum of CHM Gene Mutations in Choroideremia and Their Relationship to Clinical Phenotype.

Authors:  Matthew P Simunovic; Jasleen K Jolly; Kanmin Xue; Thomas L Edwards; Markus Groppe; Susan M Downes; Robert E MacLaren
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-11-01       Impact factor: 4.799

7.  Technique of retinal gene therapy: delivery of viral vector into the subretinal space.

Authors:  K Xue; M Groppe; A P Salvetti; R E MacLaren
Journal:  Eye (Lond)       Date:  2017-08-18       Impact factor: 3.775

Review 8.  Choroideremia: from genetic and clinical phenotyping to gene therapy and future treatments.

Authors:  Andreas Mitsios; Adam M Dubis; Mariya Moosajee
Journal:  Ther Adv Ophthalmol       Date:  2018-12-27

9.  Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia.

Authors:  Kanmin Xue; Jasleen K Jolly; Alun R Barnard; Anna Rudenko; Anna P Salvetti; Maria I Patrício; Thomas L Edwards; Markus Groppe; Harry O Orlans; Tanya Tolmachova; Graeme C Black; Andrew R Webster; Andrew J Lotery; Graham E Holder; Susan M Downes; Miguel C Seabra; Robert E MacLaren
Journal:  Nat Med       Date:  2018-10-08       Impact factor: 53.440

10.  Structural and Functional Recovery Following Limited Iatrogenic Macular Detachment for Retinal Gene Therapy.

Authors:  Matthew P Simunovic; Kanmin Xue; Jasleen K Jolly; Robert E MacLaren
Journal:  JAMA Ophthalmol       Date:  2017-03-01       Impact factor: 7.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.